A Retrospective Study on Inotuzumab Ozogamicin in Infants and Young Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

被引：2
|
作者：
Brivio, Erica [1 ,2 ]
Hoogendijk, Raoull [1 ]
Chantrain, Christophe [3 ]
Rialland, Fanny [4 ]
Contet, Audrey [5 ]
Elitzur, Sarah [6 ]
Dalla-Pozza, Luciano [7 ]
Kallay, Krisztian [8 ]
Li, Chi Kong [9 ]
Kato, Motohiro [10 ]
Markova, Inna V. [11 ]
Schmiegelow, Kjeld [12 ]
Bodmer, Nicole [13 ]
Pieters, Rob [1 ]
Zwaan, Christian Michel [1 ,2 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[2] Erasmus MC, Dept Pediat Oncol Hematol, Sophia Childrens Hosp, Rotterdam, Netherlands
[3] CHC Liege, Clin Esperance, Div Pediat Hematol Oncol, Montegnee, Belgium
[4] CHU Nantes, Nantes, France
[5] CHRU Nancy, Childrens Hosp, Dept Hematol & Oncol, Vandoeuvre Les Nancy, France
[6] Schneider Childrens Med Ctr Israel, Pediat Hematol Oncol, Petah Tiqwa, Israel
[7] Childrens Hosp Westmead, Canc Ctr Children, Westmead, NSW, Australia
[8] Cent Hosp Southern Pest, Pediat Hematol & Stem Cell Transplantat Dept, Natl Inst Hematol & Infect Dis, Budapest, Hungary
[9] Chinese Univ Hong Kong, Dept Paediat, Prince Wales Hosp, Hong Kong, Peoples R China
[10] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan
[11] First Pavlov State Med Univ St Petersburg, Raisa Gorbacheva Mem Sci Inst Children Oncol Hema, St Petersburg, Russia
[12] Rigshosp Univ Hosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark
[13] Univ Childrens Hosp Zurich, Zurich, Switzerland
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126472
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3890
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Outcome of Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients with Extramedullary Disease Receiving Inotuzumab Ozogamicin
    Kayser, Sabine
    Sartor, Chiara
    Panitz, Nydia
    Fante, Matthias
    Lutz, Christoph
    Wolff, Daniel
    Ho, Anthony
    Papayannidis, Cristina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S265 - S265
  • [42] Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
    Savoy, J. Michael
    Welch, Mary Alma
    Nasnas, Patrice E.
    Kantarjian, Hagop
    Jabbour, Elias
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (12) : 347 - 356
  • [43] Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia
    Marks, David, I
    Kebriaei, Partow
    Stelljes, Matthias
    Goekbuget, Nicola
    Kantarjian, Hagop
    Advani, Anjali S.
    Merchant, Akil
    Stock, Wendy
    Cassaday, Ryan D.
    Wang, Tao
    Zhang, Hui
    Loberiza, Fausto
    Vandendries, Erik
    DeAngelo, Daniel J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1720 - 1729
  • [44] Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review
    Marks, David I.
    Cassaday, Ryan D.
    Ribera, Josep-Maria
    Schuh, Andre C.
    Park, Jae H.
    Chiaretti, Sabina
    Stelljes, Matthias
    EXPERT REVIEW OF HEMATOLOGY, 2025, 18 (01) : 91 - 103
  • [45] Inotuzumab Ozogamicin for Patients with relapsed or refractory acute Lymphoblastic Leukemia: Effective Option also in Patients with extramedullary Disease
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (03) : 142 - 142
  • [46] Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study
    DeAngelo, Daniel J.
    Stock, Wendy
    Stein, Anthony S.
    Shustov, Andrei
    Liedtke, Michaela
    Schiffer, Charles A.
    Vandendries, Erik
    Liau, Katherine
    Ananthakrishnan, Revathi
    Boni, Joseph
    Laird, A. Douglas
    Fostvedt, Luke
    Kantarjian, Hagop M.
    Advani, Anjali S.
    BLOOD ADVANCES, 2017, 1 (15) : 1167 - 1180
  • [47] Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia
    Zaina T. Al-Salama
    Targeted Oncology, 2018, 13 : 525 - 532
  • [48] Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia
    Al-Salama, Zaina T.
    TARGETED ONCOLOGY, 2018, 13 (04) : 525 - 532
  • [49] Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia
    Kohso, Atsushi
    Toyoda, Hidemi
    Hanaki, Ryo
    Niwa, Kaori
    Okumura, Yosuke
    Morimoto, Mari
    Ito, Takahiro
    Hirayama, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (02) : 276 - 280
  • [50] Outcome of Patients with Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL) after Failure of Inotuzumab Ozogamicin
    Chahoud, Jad
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Kadia, Tapan
    Cortes, Jorge E.
    Khouri, Maria R.
    Ravandi, Farhad
    Dahl, Jenny
    Ferrajoli, Alessandra
    Jacob, Jovitta
    Pemmaraju, Naveen
    Daver, Naval
    Garris, Rebecca
    Jabbour, Elias
    BLOOD, 2015, 126 (23)
12345